A few years ago, peptides lived on biohacker forums. Now they come up at dinner, on every second podcast and in the group chat where your most optimized friend shares his “stack.”
The reactions split fast. One camp treats peptides like fairy dust. The other calls the whole thing a scam.
Both are wrong. And both skip the only question that matters: which peptide, for what and through whom?
Not fairy dust, not a scam
I’m pro-peptide. That’s exactly why I care how it’s done.
I’ve sat through enough hype cycles to know this pattern by heart. A real asset class gets hot, the hype gets ahead of the fundamentals and a grey market shows up to sell it to people who skipped the diligence. The asset isn’t the problem. The way people buy it is.
So here’s the plain-English version: what a peptide is, why the interest is real and how legitimate access works.
I’m the founder of The Vitality Collective, not a clinician, so this isn’t medical advice. It’s the explainer I wish someone had handed me.
What a peptide actually is
A peptide is a short chain of amino acids, typically 2 to 50, linked together. A longer chain is a polypeptide, and proteins are built from one or more polypeptides.
That’s it. No magic. Amino acids are the same building blocks your body gets from the protein in your food and uses to build its own proteins.
What makes peptides interesting is that some well-established medicines are peptides. They’re a real part of modern medicine, with decades of research and clinical use behind the class. I won’t name any here, because this isn’t a product page and a name without a clinician attached is how people end up shopping instead of thinking.
So what is peptide therapy? In plain terms, it generally means a licensed clinician prescribing a specific peptide for a specific reason, filled by a licensed pharmacy, with follow-up. The word “therapy” is doing real work in that sentence.
Why the interest is real
Researchers are actively studying peptides for questions high performers care about: recovery, body composition, sleep and healthy aging.
The evidence is specific to each compound and each question. Some peptides have deep clinical histories. Others are newer, and the research on them is still being built. That’s what a growing field looks like. Every serious area of medicine went through the same phase: early signals, better studies, clearer answers. It’s also why “peptides work” and “peptides don’t work” are both useless sentences. The real question is which one, for what and in whom.
What we know vs. what we don’t yet
Short version:
- What we know: peptides are a legitimate class of molecules, and some are established medicines.
- What’s still being built: the evidence behind many of the newer, popular uses.
Reading that evidence well is a skill. On Thursday I’ll walk through how to do it, the same way you’d run diligence on a deal before you wire money.
How legitimate access works
This is the part the grey market hopes you skip.
Think about how you’d buy a stake in a private company. You wouldn’t send a wire to a stranger because his pitch deck had nice fonts. You’d want audited numbers, a lawyer who reads the documents and someone accountable on the other side. Peptides deserve the same standard, because the asset is going into your body, not your brokerage account.
Here’s what doing it properly generally looks like, whoever you go through:
- In most cases, labs come first. Your baseline tells a clinician what’s actually going on before anyone talks treatment.
- A licensed clinician decides. They decide whether anything is clinically appropriate for you, based on your history, your labs and your goals.
- A licensed pharmacy fills the prescription. Not a website with a discount code.
- There’s follow-up. Someone checks in, and you know how to reach them with questions.
- “No” or “not yet” is an acceptable answer. A provider that never says either isn’t evaluating you. It’s selling to you.
And here’s the line on the stuff sold online: Products sold online as “research use only” or “not for human consumption” aren’t intended for people and aren’t prescribed through a clinician. Their quality is unknown, and they carry real safety risks.
If the label tells you it isn’t for humans, believe the label.
I’ll say it plainly, because it’s the whole reason I’m writing this: being pro-peptide means being against the grey market. Every person who gets hurt by a mystery vial becomes another headline that makes the legitimate side of this field harder to talk about. The front door protects you, and it protects the field.
Five questions to ask any peptide provider
Before you start anything, ask:
- Who evaluates me? Is a licensed clinician reviewing my history and deciding whether it’s appropriate?
- Do we start with labs? And who reviews them with me?
- Which licensed pharmacy fills it?
- Who follows up? How often, and how do I reach them?
- Is “not yet” an acceptable answer? If the answer is no, you have your answer.
If a provider gets defensive about any of these, that tells you more than their website does.
If you’re weighing testosterone too, the same discipline applies. I wrote about the question most men skip in Thinking About TRT? Have the Family-Planning Conversation First.
A real field deserves to be done properly
This is a real field with real science behind it. That’s why it deserves to be done properly: in most cases labs first, a licensed clinician, a licensed pharmacy and follow-up.
Pro-peptide and pro-front-door aren’t opposites. They’re the same position.
Go deeper
The Hormone Reset Blueprint includes a full chapter introducing peptides (Chapter 6), alongside the labs and fundamentals that come first.
Get the Hormone Reset Blueprint →
Would you rather talk it through? Request a Private Call. Available nationwide. Some visit requirements vary by state. Medical care through The Vitality Collective is provided by independent licensed clinicians.
— Charles
Sources
- National Human Genome Research Institute. Peptide. Talking Glossary of Genomic and Genetic Terms. https://www.genome.gov/genetics-glossary/Peptide
- Wang L, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022;7:48. https://doi.org/10.1038/s41392-022-00904-4
- Cushman CJ, et al. Local and Systemic Peptide Therapies for Soft Tissue Regeneration: A Narrative Review. Yale J Biol Med. 2024;97(3):399-413. https://doi.org/10.59249/TKNM3388
- Sigalos JT, Pastuszak AW. The Safety and Efficacy of Growth Hormone Secretagogues. Sex Med Rev. 2018;6(1):45-53. https://doi.org/10.1016/j.sxmr.2017.02.004
- Baker LD, et al. Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial. Arch Neurol. 2012;69(11):1420-1429. https://doi.org/10.1001/archneurol.2012.1970
- U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
Educational only, not medical advice. I’m the founder of The Vitality Collective, not a clinician. Talk with a licensed clinician before starting any treatment. Some medications a clinician may prescribe are not FDA-approved. Medical care through The Vitality Collective is provided by independent licensed clinicians. Individual results vary. Available nationwide. Some visit requirements vary by state.